annual CFI:
-$2.47B+$717.00M(+22.51%)Summary
- As of today (June 28, 2025), REGN annual cash flow from investing activities is -$2.47 billion, with the most recent change of +$717.00 million (+22.51%) on December 31, 2024.
- During the last 3 years, REGN annual CFI has risen by +$2.92 billion (+54.16%).
- REGN annual CFI is now -2021.13% below its all-time high of $128.47 million, reached on December 31, 2011.
Performance
REGN Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$647.50M+$296.90M(+84.68%)Summary
- As of today (June 28, 2025), REGN quarterly cash flow from investing activities is $647.50 million, with the most recent change of +$296.90 million (+84.68%) on March 31, 2025.
- Over the past year, REGN quarterly CFI has increased by +$2.33 billion (+138.38%).
- REGN quarterly CFI is now -55.45% below its all-time high of $1.45 billion, reached on June 30, 2020.
Performance
REGN quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$133.50M+$2.33B(+94.59%)Summary
- As of today (June 28, 2025), REGN TTM cash flow from investing activities is -$133.50 million, with the most recent change of +$2.33 billion (+94.59%) on March 31, 2025.
- Over the past year, REGN TTM CFI has increased by +$4.50 billion (+97.12%).
- REGN TTM CFI is now -122.46% below its all-time high of $594.50 million, reached on June 30, 2020.
Performance
REGN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
REGN Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.5% | +138.4% | +97.1% |
| 3 y3 years | +54.2% | +138.0% | +97.8% |
| 5 y5 years | -21.7% | +246.1% | +92.1% |
REGN Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +54.2% | at high | +127.1% | at high | +98.0% |
| 5 y | 5-year | -3395.9% | +54.2% | -55.5% | +126.5% | -122.5% | +98.0% |
| alltime | all time | -2021.1% | +54.2% | -55.5% | +126.5% | -122.5% | +98.0% |
REGN Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $647.50M(+84.7%) | -$133.50M(-94.6%) |
| Dec 2024 | -$2.47B(-22.5%) | $350.60M(-161.0%) | -$2.47B(-14.4%) |
| Sep 2024 | - | -$574.40M(+3.1%) | -$2.88B(+2.8%) |
| Jun 2024 | - | -$557.20M(-67.0%) | -$2.81B(-39.5%) |
| Mar 2024 | - | -$1.69B(+2448.5%) | -$4.64B(+45.6%) |
| Dec 2023 | -$3.19B(-15.8%) | -$66.20M(-86.7%) | -$3.19B(-36.0%) |
| Sep 2023 | - | -$496.30M(-79.2%) | -$4.98B(+16.1%) |
| Jun 2023 | - | -$2.39B(+912.7%) | -$4.29B(+85.2%) |
| Mar 2023 | - | -$235.70M(-87.3%) | -$2.31B(-38.8%) |
| Dec 2022 | -$3.78B(-29.7%) | -$1.86B(-1066.0%) | -$3.78B(-3.9%) |
| Sep 2022 | - | $192.30M(-146.5%) | -$3.94B(-40.0%) |
| Jun 2022 | - | -$413.90M(-75.7%) | -$6.57B(+8.9%) |
| Mar 2022 | - | -$1.71B(-15.3%) | -$6.03B(+12.0%) |
| Dec 2021 | -$5.38B(+7527.1%) | -$2.01B(-17.5%) | -$5.38B(+46.4%) |
| Sep 2021 | - | -$2.44B(-2038.6%) | -$3.68B(+82.6%) |
| Jun 2021 | - | $125.80M(-111.9%) | -$2.01B(+193.4%) |
| Mar 2021 | - | -$1.06B(+247.2%) | -$686.40M(+872.2%) |
| Dec 2020 | -$70.60M(-96.5%) | -$305.00M(-60.7%) | -$70.60M(-374.7%) |
| Sep 2020 | - | -$775.80M(-153.4%) | $25.70M(-95.7%) |
| Jun 2020 | - | $1.45B(-427.9%) | $594.50M(-135.1%) |
| Mar 2020 | - | -$443.20M(+112.4%) | -$1.69B(-16.4%) |
| Dec 2019 | -$2.03B(+38.6%) | -$208.70M(+0.8%) | -$2.03B(-2.7%) |
| Sep 2019 | - | -$207.00M(-75.2%) | -$2.08B(-3.7%) |
| Jun 2019 | - | -$836.00M(+7.7%) | -$2.16B(+19.4%) |
| Mar 2019 | - | -$776.10M(+191.9%) | -$1.81B(+24.0%) |
| Dec 2018 | -$1.46B(+45.5%) | -$265.90M(-7.3%) | -$1.46B(-4.6%) |
| Sep 2018 | - | -$286.70M(-40.9%) | -$1.53B(-4.5%) |
| Jun 2018 | - | -$485.00M(+14.0%) | -$1.61B(+24.4%) |
| Mar 2018 | - | -$425.40M(+26.7%) | -$1.29B(+28.4%) |
| Dec 2017 | -$1.01B(-4.0%) | -$335.76M(-6.4%) | -$1.01B(+6.9%) |
| Sep 2017 | - | -$358.88M(+110.6%) | -$940.69M(-4.8%) |
| Jun 2017 | - | -$170.41M(+21.6%) | -$987.66M(-13.6%) |
| Mar 2017 | - | -$140.14M(-48.3%) | -$1.14B(+9.2%) |
| Dec 2016 | -$1.05B(+15.3%) | -$271.25M(-33.2%) | -$1.05B(+16.5%) |
| Sep 2016 | - | -$405.85M(+24.5%) | -$898.85M(+15.8%) |
| Jun 2016 | - | -$326.01M(+646.3%) | -$776.17M(-5.6%) |
| Mar 2016 | - | -$43.69M(-64.6%) | -$821.80M(-9.5%) |
| Dec 2015 | -$907.60M(+115.7%) | -$123.30M(-56.5%) | -$907.60M(+24.7%) |
| Sep 2015 | - | -$283.17M(-23.8%) | -$727.66M(+28.2%) |
| Jun 2015 | - | -$371.65M(+187.0%) | -$567.55M(+80.7%) |
| Mar 2015 | - | -$129.48M(-328.6%) | -$314.03M(-25.4%) |
| Dec 2014 | -$420.78M(+18.4%) | $56.65M(-146.0%) | -$420.78M(-28.4%) |
| Sep 2014 | - | -$123.07M(+4.2%) | -$587.37M(-13.5%) |
| Jun 2014 | - | -$118.12M(-50.0%) | -$678.75M(+52.9%) |
| Mar 2014 | - | -$236.23M(+114.9%) | -$444.00M(+24.9%) |
| Dec 2013 | -$355.45M(+338.4%) | -$109.95M(-48.7%) | -$355.45M(+130.2%) |
| Sep 2013 | - | -$214.45M(-283.9%) | -$154.40M(-1467.1%) |
| Jun 2013 | - | $116.63M(-179.0%) | $11.29M(-104.6%) |
| Mar 2013 | - | -$147.69M(-262.1%) | -$244.52M(+201.6%) |
| Dec 2012 | -$81.07M(-163.1%) | $91.10M(-286.9%) | -$81.07M(-60.7%) |
| Sep 2012 | - | -$48.75M(-65.0%) | -$206.08M(+30.2%) |
| Jun 2012 | - | -$139.19M(-982.8%) | -$158.23M(-227.7%) |
| Mar 2012 | - | $15.77M(-146.5%) | $123.89M(-3.6%) |
| Dec 2011 | $128.47M(-129.4%) | -$33.91M(+3655.0%) | $128.47M(-166.8%) |
| Sep 2011 | - | -$903.00K(-100.6%) | -$192.24M(+36.2%) |
| Jun 2011 | - | $142.94M(+602.5%) | -$141.17M(-49.6%) |
| Mar 2011 | - | $20.35M(-105.7%) | -$280.28M(-35.9%) |
| Dec 2010 | -$437.03M(<-9900.0%) | -$354.62M(-806.8%) | -$437.03M(+330.2%) |
| Sep 2010 | - | $50.17M(+1213.4%) | -$101.58M(-38.5%) |
| Jun 2010 | - | $3.82M(-102.8%) | -$165.22M(+70.8%) |
| Mar 2010 | - | -$136.40M(+611.5%) | -$96.72M(<-9900.0%) |
| Dec 2009 | $146.00K(-99.5%) | -$19.17M(+42.3%) | $146.00K(-99.9%) |
| Sep 2009 | - | -$13.47M(-118.6%) | $103.99M(-42.3%) |
| Jun 2009 | - | $72.33M(-282.9%) | $180.24M(-486.2%) |
| Mar 2009 | - | -$39.54M(-146.7%) | -$46.67M(-251.4%) |
| Dec 2008 | $30.82M | $84.67M(+34.9%) | $30.82M(-277.2%) |
| Sep 2008 | - | $62.78M(-140.6%) | -$17.39M(-78.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2008 | - | -$154.58M(-507.4%) | -$82.04M(-411.6%) |
| Mar 2008 | - | $37.94M(+4.1%) | $26.33M(-130.7%) |
| Dec 2007 | -$85.72M(-44.7%) | $36.46M(-2045.7%) | -$85.72M(-70.0%) |
| Sep 2007 | - | -$1.87M(-95.9%) | -$285.40M(+31.5%) |
| Jun 2007 | - | -$46.20M(-37.7%) | -$217.06M(-0.6%) |
| Mar 2007 | - | -$74.11M(-54.6%) | -$218.35M(+40.8%) |
| Dec 2006 | -$155.10M(-234.3%) | -$163.21M(-345.6%) | -$155.10M(-564.2%) |
| Sep 2006 | - | $66.46M(-240.0%) | $33.41M(+162.1%) |
| Jun 2006 | - | -$47.48M(+336.8%) | $12.75M(-85.2%) |
| Mar 2006 | - | -$10.87M(-143.0%) | $86.20M(-25.4%) |
| Dec 2005 | $115.49M(-2620.1%) | $25.30M(-44.8%) | $115.49M(+27.8%) |
| Sep 2005 | - | $45.80M(+76.4%) | $90.35M(+134.3%) |
| Jun 2005 | - | $25.97M(+40.9%) | $38.57M(-164.9%) |
| Mar 2005 | - | $18.43M(>+9900.0%) | -$59.39M(+1195.9%) |
| Dec 2004 | -$4.58M(-92.8%) | $163.00K(-102.7%) | -$4.58M(-97.2%) |
| Sep 2004 | - | -$5.99M(-91.7%) | -$161.24M(+65.2%) |
| Jun 2004 | - | -$71.99M(-198.3%) | -$97.62M(+86.2%) |
| Mar 2004 | - | $73.23M(-146.8%) | -$52.43M(-17.9%) |
| Dec 2003 | -$63.84M(+9.1%) | -$156.49M(-371.6%) | -$63.84M(-150.0%) |
| Sep 2003 | - | $57.63M(-315.1%) | $127.58M(+27.5%) |
| Jun 2003 | - | -$26.80M(-143.3%) | $100.06M(+10.9%) |
| Mar 2003 | - | $61.82M(+77.0%) | $90.23M(-254.2%) |
| Dec 2002 | -$58.52M(-22.4%) | $34.94M(+16.1%) | -$58.52M(-51.1%) |
| Sep 2002 | - | $30.10M(-182.2%) | -$119.66M(-30.1%) |
| Jun 2002 | - | -$36.63M(-57.9%) | -$171.25M(+1.2%) |
| Mar 2002 | - | -$86.93M(+231.7%) | -$169.20M(+124.4%) |
| Dec 2001 | -$75.39M(+30.7%) | -$26.21M(+22.0%) | -$75.39M(+18.0%) |
| Sep 2001 | - | -$21.49M(-37.9%) | -$63.91M(-27.5%) |
| Jun 2001 | - | -$34.58M(-602.1%) | -$88.10M(+65.3%) |
| Mar 2001 | - | $6.89M(-146.7%) | -$53.30M(-7.6%) |
| Dec 2000 | -$57.68M(-437.3%) | -$14.73M(-67.7%) | -$57.68M(+14.8%) |
| Sep 2000 | - | -$45.68M(<-9900.0%) | -$50.24M(-905.8%) |
| Jun 2000 | - | $226.00K(-91.0%) | $6.24M(-36.4%) |
| Mar 2000 | - | $2.51M(-134.4%) | $9.81M(-42.6%) |
| Dec 1999 | $17.10M(+584.0%) | -$7.30M(-167.6%) | $17.10M(-38.0%) |
| Sep 1999 | - | $10.80M(+184.2%) | $27.60M(+112.3%) |
| Jun 1999 | - | $3.80M(-61.2%) | $13.00M(-24.9%) |
| Mar 1999 | - | $9.80M(+206.3%) | $17.30M(+592.0%) |
| Dec 1998 | $2.50M(-106.4%) | $3.20M(-184.2%) | $2.50M(-117.7%) |
| Sep 1998 | - | -$3.80M(-146.9%) | -$14.10M(-26.2%) |
| Jun 1998 | - | $8.10M(-262.0%) | -$19.10M(-54.2%) |
| Mar 1998 | - | -$5.00M(-62.7%) | -$41.70M(+7.2%) |
| Dec 1997 | -$38.90M(-12.2%) | -$13.40M(+52.3%) | -$38.90M(+2.6%) |
| Sep 1997 | - | -$8.80M(-39.3%) | -$37.90M(+16.3%) |
| Jun 1997 | - | -$14.50M(+559.1%) | -$32.60M(-0.6%) |
| Mar 1997 | - | -$2.20M(-82.3%) | -$32.80M(-26.0%) |
| Dec 1996 | -$44.30M(-698.6%) | -$12.40M(+254.3%) | -$44.30M(+53.3%) |
| Sep 1996 | - | -$3.50M(-76.2%) | -$28.90M(+18.4%) |
| Jun 1996 | - | -$14.70M(+7.3%) | -$24.40M(+916.7%) |
| Mar 1996 | - | -$13.70M(-556.7%) | -$2.40M(-132.4%) |
| Dec 1995 | $7.40M(-76.8%) | $3.00M(+200.0%) | $7.40M(-67.5%) |
| Sep 1995 | - | $1.00M(-86.3%) | $22.80M(-10.6%) |
| Jun 1995 | - | $7.30M(-287.2%) | $25.50M(+8.1%) |
| Mar 1995 | - | -$3.90M(-121.2%) | $23.60M(-26.0%) |
| Dec 1994 | $31.90M(-235.2%) | $18.40M(+397.3%) | $31.90M(-878.0%) |
| Sep 1994 | - | $3.70M(-31.5%) | -$4.10M(-80.4%) |
| Jun 1994 | - | $5.40M(+22.7%) | -$20.90M(+2.0%) |
| Mar 1994 | - | $4.40M(-125.0%) | -$20.50M(-13.1%) |
| Dec 1993 | -$23.60M(-387.8%) | -$17.60M(+34.4%) | -$23.60M(+807.7%) |
| Sep 1993 | - | -$13.10M(-325.9%) | -$2.60M(-122.2%) |
| Jun 1993 | - | $5.80M(+346.2%) | $11.70M(+56.0%) |
| Mar 1993 | - | $1.30M(-61.8%) | $7.50M(-8.5%) |
| Dec 1992 | $8.20M(-110.6%) | $3.40M(+183.3%) | $8.20M(+70.8%) |
| Sep 1992 | - | $1.20M(-25.0%) | $4.80M(+33.3%) |
| Jun 1992 | - | $1.60M(-20.0%) | $3.60M(+80.0%) |
| Mar 1992 | - | $2.00M | $2.00M |
| Dec 1991 | -$77.60M | - | - |
FAQ
- What is Regeneron Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual CFI year-on-year change?
- What is Regeneron Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly CFI year-on-year change?
- What is Regeneron Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM CFI year-on-year change?
What is Regeneron Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of REGN is -$2.47B
What is the all time high annual CFI for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual cash flow from investing activities is $128.47M
What is Regeneron Pharmaceuticals annual CFI year-on-year change?
Over the past year, REGN annual cash flow from investing activities has changed by +$717.00M (+22.51%)
What is Regeneron Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of REGN is $647.50M
What is the all time high quarterly CFI for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly cash flow from investing activities is $1.45B
What is Regeneron Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, REGN quarterly cash flow from investing activities has changed by +$2.33B (+138.38%)
What is Regeneron Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of REGN is -$133.50M
What is the all time high TTM CFI for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM cash flow from investing activities is $594.50M
What is Regeneron Pharmaceuticals TTM CFI year-on-year change?
Over the past year, REGN TTM cash flow from investing activities has changed by +$4.50B (+97.12%)